Literature DB >> 1601289

Endoglucanase A from Cellulomonas fimi in which the hinge sequence of human IgA1 is substituted for the linker connecting its two domains is hydrolyzed by IgA proteases from Neisseria gonorrhoeae.

P B Miller1, H Shen, N R Gilkes, D G Kilburn, R C Miller, A G Plaut, R A Warren.   

Abstract

The hinge in IgA1 and the linker in endoglucanase A (CenA) are quite similar. The IgA1 hinge is 18 amino acids long and contains only proline, threonine and serine. The linker in CenA is 27 amino acids long and contains only proline, threonine and a single serine. IgA proteases from Neisseria gonorrhoeae cleave Pro-Ser and Pro-Thr bonds within the IgA1 hinge sequence, but they do not attack CenA. When the linker sequence of CenA is replaced with the hinge sequence of IgA1, the hybrid polypeptide is susceptible to the N. gonorrhoeae proteases. It is cleaved within the hinge sequence at the same sites as IgA1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601289     DOI: 10.1016/0378-1097(92)90512-m

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases.

Authors:  Bernard W Senior; Jenny M Woof
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA.

Authors:  Koteswara R Chintalacharuvu; Philip D Chuang; Ashley Dragoman; Christine Z Fernandez; Jiazhou Qiu; Andrew G Plaut; K Ryan Trinh; Françoise A Gala; Sherie L Morrison
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Relaxed cleavage specificity of an immunoglobulin A1 protease from Neisseria meningitidis.

Authors:  Srdjan Vitovski; Jon R Sayers
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.